Novartis

Posted on Sunday, February 1, 2004 - 07:00, By: ALSN Staff
Study of new compound open The international pharmaceutical company Novartis has opened a large-scale, dose-finding trial of a compound called TCH346 for treatment of ALS.

Advertisements

myMuscleTeam